Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-19

FDA Approved: CANDESARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for candesartan from Macleods Pharmaceuticals Limited, enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candesartan (candesartan)

Snippet

SUPPL AP for CANDESARTAN (CANDESARTAN)